Team
Heiner Dreismann, PhD
Director, Shrink Nanotechnologies, Inc.
Heiner Dreismann, Ph.D. is an international executive with more than 24 years experience in the biotech and healthcare industries. Dr. Dreismann served as the President and CEO of Roche Molecular Systems, Inc., from 2000-2006, leading a staff of more than 1,600 and growing the RMS molecular IVD business from $640M to $1.2B in annual sales. Prior to serving as the senior executive at Roche Molecular Systems, Inc., Dr. Dreismann served as the Head of Global Business Development at Roche Diagnostics, responsible for business development for the Roche Diagnostics $7B IVD business. Dr. Dreismann’s post-doctoral fellowship was earned at the French Center for Nuclear Research in Saclay (near Paris). He earned his Masters Degree Diploma in Biology from Westfaelische Wilhelms University, Muenster, a Ph.D. in Microbiology/Molecular Biology from Westfaelische Wilhelms University, Muenster (summa cum laude).
Marshall Khine
Director, Shrink Nanotechnologies
Marshall Khine is an Assistant District Attorney for the San Francisco District Attorney’s Office. For the past four years, Mr. Khine has served on the Homicide Trial Team prosecuting murder cases. He has been a trial lawyer for over ten years with extensive experience in many areas of complex litigation. He graduated from Cornell University in Ithaca, New York in 1994. He attended California Western School of Law in San Diego, California on a full academic scholarship and graduated early with honors in 1997. While in law school and after law school, he worked for the In-house Legal Department of Cubic Corporation in San Diego. Since 1998, Mr. Khine has resided in the San Francisco Bay Area.
Michelle Khine, PhD
Scientific Research and Development, Founder
Assistant Professor
Michelle Khine, PhD is the scientific founder of the Shrink nano-technology platform and a veteran entrepreneur, with a successful venture-capitalist (Series B) backed company Fluxion Biosciences located in San Francisco. She is a widely published researcher, with multiple patents grants and honors. Dr. Khine is on several review committees, most notably the Center for Scientific Review at the National Institute of Health. She is Assistant Professor of Bioengineering. Dr. Khine holds PhD, M.S. and B.S. degrees from the University of California Berkeley.
Sayantani Ghosh, PhD
Scientific Research and Development
Assistant Professor
Sayatani Ghosh, PhD is an Assistant Professor and has performed significant research and is published in the fields of spintronics, liquid crystal quantum dot ensembles, plasmonics, and photovoltaics. Dr. Ghosh holds MS and PhD degrees from the University of Chicago, USA; a BA degree from the University of Cambridge, UK; and a BS degree from St. Stephen’s College, India.
Fabian Pease, PhD
Scientific Advisory Board Chairman
Professor of Electrical Engineering, Stanford University
Fabian Pease, PhD is Professor of Electrical Engineering at Stanford University where his group’s areas of research include micro- and nano-fabrication and their application to electronic and magnetic devices and structures. Dr. Pease conducted research on the synthesis of DNA microarrays at Affymetrix Corporation and initiated programs in Advanced Microelectronics and Molecular-Level Printing the Defense Advanced Research Projects Agency. He has served as a consultant to IBM, Xerox, Etec Systems, and Lawrence Livermore Labs and is on the Technical Advisory Boards of Ultratech Stepper, San Jose, CA and Affymetrix, Santa Clara, CA. He has published over 200 articles and authored several book chapters. Dr. Pease holds BA, MA, and PhD degrees from Cambridge University, United Kingdom.
Kara McCloskey, PhD
Scientific Advisory Board Member
Assistant Professor
Kara McCloskey, PhD is Professor at School of Engineering, Universiy of California, Merced. She has conducted significant research in the field of tissue engineering with a specific focus on the cardiovascular system and stem cells. Professor McCloskey received a BS and an MS from Ohio State University and a PhD from Cleveland Clinic Foundation, conferred by Ohio State University.
Bruce R. Conklin, MD
Scientific Advisory Board
Professor
Bruce R. Conklin, MD, is a Senior Investigator at the Gladstone Institute of Cardiovascular Disease and a Professor at the University of California, San Francisco, with appointments in the Departments of Medicine and Cellular and Molecular Pharmacology. His research combines genetic techniques and bioinformatics to study G-Protein Couple Receptor hormone signaling involved in murine embryonic stem cells (mESC) and pluripotent embryonic stem (ES) cells. The cell lines can be used in to analyze toxic side effects of pharmaceuticals and study the differentiation of embryonic stem cells into cardiac tissues. Dr. Conklin served as the founding director of the Gladstone Genomics Core and is currently the founding director of the Gladstone Stem Cell Core. From 1995 to 2001, Dr. Conklin was the Associate Director of the General Clinical Research Center at San Francisco General Hospital. He is a member of several honorary societies including the American Society for Clinical Investigation. Dr. Conklin was the co-chair of the UCSF public science project in 1994, and is co-chair of the UCSF-California Academy of Sciences Affiliation Task Force. Dr. Conklin is the Associate Director of the Gladstone CIRM Scholars Training Program, and the recipient of a CIRM New Stem Cell Lines grant. Dr. Conklin is a key advisor to iPierian, Inc., a Kleiner Perkins-backed biopharmaceutical company located in San Francisco.
